Skip to main content

Advertisement

Log in

Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC)

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Background and aims

Limited data exist regarding outcomes of acute variceal bleeding (AVB) in patients with acute-on-chronic liver failure (ACLF), especially in those with hepatic failure. We evaluated the outcomes of AVB in patients with ACLF in a multinational cohort of APASL ACLF Research Consortium (AARC).

Methods

Prospectively maintained data from AARC database on patients with ACLF who developed AVB (ACLF-AVB) was analysed. This data included demographic profile, severity of liver disease, and rebleeding and mortality in 6 weeks. These outcomes were compared with a propensity score matched (PSM) cohort of ACLF matched for severity of liver disease (MELD, AARC score) without AVB (ACLF without AVB).

Results

Of the 4434 ACLF patients, the outcomes in ACLF-AVB (n = 72) [mean age—46 ± 10.4 years, 93% males, 66% with alcoholic liver disease, 65% with alcoholic hepatitis, AARC score: 10.1 ± 2.2, MELD score: 34 (IQR: 27–40)] were compared with a PSM cohort selected in a ratio of 1:2 (n = 143) [mean age—44.9 ± 12.5 years, 82.5% males, 48% alcoholic liver disease, 55.7% alcoholic hepatitis, AARC score: 9.4 ± 1.5, MELD score: 32 (IQR: 24–40)] of ACLF-without AVB. Despite PSM, ACLF patients with AVB had a higher baseline HVPG than without AVB (25.00 [IQR: 23.00–28.00] vs. 17.00 [15.00–21.75] mmHg; p = 0.045). The 6-week mortality in ACLF patients with or without AVB was 70.8% and 53.8%, respectively (p = 0.025). The 6-week rebleeding rate was 23% in ACLF-AVB. Presence of ascites [hazard ratio (HR) 2.2 (95% CI 1.03–9.8), p = 0.026], AVB [HR 1.9 (95% CI 1.2–2.5, p = 0.03)], and MELD score [HR 1.7 (95% CI 1.1–2.1), p = 0.001] independently predicted mortality in the overall ACLF cohort.

Conclusion

Development of AVB confers poor outcomes in patients with ACLF with a high 6-week mortality. Elevated HVPG at baseline represents a potential risk factor for future AVB in ACLF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

ACLF:

Acute on chronic liver failure

APASL:

Asia Pacific association for study of liver diseases

AVB:

Acute variceal bleeding

AARC:

APASL ACLF Research Consortium

HVPG:

Hepatic venous pressure gradient

MELD:

Model for end stage liver disease

PSM:

Propensity score matching

SOFA:

Sequential organ failure assessment

References

  1. Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–390. https://doi.org/10.1007/s12072-019-09946-3

    Article  PubMed  Google Scholar 

  2. Augustin S, Muntaner L, Altamirano JT, et al. Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis. Clin Gastroenterol Hepatol. 2009;7(12):1347–1354. https://doi.org/10.1016/j.cgh.2009.08.011

    Article  PubMed  Google Scholar 

  3. Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol. 2003;98(3):653–659. https://doi.org/10.1111/j.1572-0241.2003.07294.x

    Article  PubMed  Google Scholar 

  4. Reverter E, Tandon P, Augustin S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146(2):412-419.e3. https://doi.org/10.1053/j.gastro.2013.10.018

    Article  PubMed  Google Scholar 

  5. Rout G, Sharma S, Gunjan D, et al. Development and validation of a novel model for outcomes in patients with cirrhosis and acute variceal bleeding. Dig Dis Sci. 2019;64(8):2327–2337. https://doi.org/10.1007/s10620-019-05557-y

    Article  PubMed  Google Scholar 

  6. Trebicka J, Gu W, Ibáñez-Samaniego L, et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. J Hepatol. 2020. https://doi.org/10.1016/j.jhep.2020.04.024

    Article  PubMed  Google Scholar 

  7. Kumar R, Kerbert AJC, Sheikh MF, et al. Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding. J Hepatol. 2021;74(1):66–79. https://doi.org/10.1016/j.jhep.2020.06.010

    Article  PubMed  Google Scholar 

  8. Sarin SK, Kumar A, Angus PW, et al. Diagnosis and management of acute variceal bleeding: Asian Pacific Association for study of the liver recommendations. Hepatol Int. 2011;5(2):607–624. https://doi.org/10.1007/s12072-010-9236-9

    Article  PubMed  PubMed Central  Google Scholar 

  9. de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752. https://doi.org/10.1016/j.jhep.2015.05.022

    Article  PubMed  Google Scholar 

  10. Garg H, Kumar A, Garg V, et al. Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure. J Gastroenterol Hepatol. 2013;28(8):1361–1367. https://doi.org/10.1111/jgh.12191

    Article  PubMed  Google Scholar 

  11. Mookerjee RP, Pavesi M, Thomsen KL, et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J Hepatol. 2016;64(3):574–582. https://doi.org/10.1016/j.jhep.2015.10.018

    Article  CAS  PubMed  Google Scholar 

  12. Kumar M, Kainth S, Choudhury A, et al. Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial. Hepatol Int. 2019;13(6):800–813. https://doi.org/10.1007/s12072-019-09986-9

    Article  PubMed  Google Scholar 

  13. Bhutta AQ, Garcia-Tsao G, Reddy KR, et al. Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation. Aliment Pharmacol Ther. 2018;47(1):78–85. https://doi.org/10.1111/apt.14366

    Article  CAS  PubMed  Google Scholar 

  14. Tergast TL, Kimmann M, Laser H, et al. Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis. Aliment Pharmacol Ther. 2019;50(6):696–706. https://doi.org/10.1111/apt.15439

    Article  CAS  PubMed  Google Scholar 

  15. García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–2379. https://doi.org/10.1056/NEJMoa0910102

    Article  PubMed  Google Scholar 

  16. Lv Y, Yang Z, Liu L, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4(8):587–598. https://doi.org/10.1016/S2468-1253(19)30090-1

    Article  PubMed  Google Scholar 

  17. de Franchis R, Bosch J, Garcia-Tsao G, et al. BAVENO VII—RENEWING CONSENSUS IN PORTAL HYPERTENSION: report of the Baveno VII consensus workshop: personalized care in portal hypertension. J Hepatol. 2021. https://doi.org/10.1016/j.jhep.2021.12.022

    Article  PubMed  Google Scholar 

  18. Nicoară-Farcău O, Han G, Rudler M, et al. Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data. Gastroenterology. 2021;160(1):193-205.e10. https://doi.org/10.1053/j.gastro.2020.09.026

    Article  CAS  PubMed  Google Scholar 

  19. Shalimar, Sharma S, Gamanagatti SR, et al. Acute-on-chronic liver failure in budd-chiari syndrome: profile and predictors of outcome. Dig Dis Sci 2020;65(9):2719–2729. https://doi.org/10.1007/s10620-019-06005-7

Download references

Acknowledgements

APASL ACLF working Party Collaborators Detail: Shiv Kumar Sarin, Ashok Choudhury, Manoj K. Sharma, Rakhi Maiwall, Mamun Al Mahtab, Salimur Rahman, Sanjiv Saigal, Neeraj Saraf, A. S. Soin, Harshad Devarbhavi, Dong Joon Kim, R. K. Dhiman, Ajay Duseja, Sunil Taneja, C. E. Eapen, Ashish Goel, Q. Ning, Tao Chen, Ke Ma, Z. Duan, Chen Yu, Sombat Treeprasertsuk, S. S. Hamid, Amna S. Butt, Wasim Jafri, Akash Shukla, Vivek Saraswat, Soek Siam Tan, Ajit Sood, Vandana Midha, Omesh Goyal, Hasmik Ghazinyan, Anil Arora, Jinhua Hu, Manoj Sahu, P. N. Rao, Guan H. Lee, Seng G. Lim, Laurentius A. Lesmana, Cosmas Rinaldi Lesmana, Samir Shah, V. G. Mohan Prasad, Diana A. Payawal, Zaigham Abbas, A. Kadir Dokmeci, Jose D. Sollano, Gian Carpio, Ananta Shresta, G. K. Lau, Md. Fazal Karim, Gamal Shiha, Rino Gani, Kemal Fariz Fariz Kalista, Man-Fung Yuen, Seema Alam, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal, Viniyendra Pamecha, Ankur Jindal, V. Rajan, Vinod Arora, Osamu Yokosuka, Madunil A. Niriella, Hai Li, Xiaolong Qi, Atsushi Tanaka, Satoshi Mochida, Dominic Ray Chaudhuri, Ed Gane, Khin Maung Win, Wei Ting Chen, Mohd Rela, Dharmesh Kapoor, Amit Rastogi, Pratibha Kale, Archana Rastogi, Chhagan Bihari Sharma, Meenu Bajpai, Virender Singh, Madhumita Premkumar, Sudhir Sudhir, A. Olithselvan, Cyriac Abby Philips, Anshu Srivastava, Surender K. Yachha, Zeeshan Ahmad Wani, B. R. Thapa, Anoop Saraya, Shalimar, Ashish Kumar, Manav Wadhawan, Subash Gupta, Kaushal Madan, Puja Sakhuja, Vivek Vij, Barjesh C. Sharma, Hitendra Garg, Vishal Garg, Chetan Kalal, Lovkesh Anand, Tanmay Vyas, Rajan P. Mathur, Guresh Kumar, Priyanka Jain, Samba Siva Rao Pasupuleti, Yogesh K. Chawla, Abhijit Chowdhury, Shahinul Alam, Do Seon Song, Jin Mo Yang.

Funding

Authors have nothing to declare for any funding.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

SS: conceptualisation, writing of original draft and revision. SA: conceptualisation, statistical analysis, revision of draft. AS: study design, conceptualisation and visualisation, study overview and critical revision of draft. AC: data collection and critical revision of the draft. MAM: data collection. MSA: data collection. SS: data collection. DJK: data collection. CEE: data collection. AG: data collection. QN team: data collection. HD: data collection. VS: data collection. AS: data collection. SH: Data collection. JH: data collection. S-ST: data collection. AA: data collection. MKS: data collection. MR: data collection. DJ: data collection. PNR: data collection. AK: data collection. HG: data collection. Guan Huei Lee: data collection. DZ: data collection. AS: data collection. OG: data collection. LAL: data collection. RCL: data collection. ST: data collection. NY: data collection. SS: data collection. HT: data collection. VMD: data collection. XS: data collection. FK: data collection. ZA: data collection. JDS: data collection. KFK: data collection. AS: data collection. DP: data collection. MO: data collection. SKS: study design, conceptualisation and visualisation, study overview and critical revision of draft.

Corresponding authors

Correspondence to Anoop Saraya or Shiv Kumar Sarin.

Ethics declarations

Conflict of interest

Sanchit Sharma, Samagra Agarwal, Anoop Saraya, Ashok Choudhury, Mamun Al Mahtab, Mohd. Shahinul Alam, Sanjiv Saigal, Dong Joon Kim, C. E. Eapen, Ashish Goel, Qin Ning, Harshad Devarbhavi, Virendra Singh, Akash Shukla, Saeed Hamid, Jinhua Hu, Soek-Siam Tan, Anil Arora, Manoj Kumar Sahu, Mohd. Rela, Dinesh Jothimani, P. N. Rao, Anand Kulkarni, Hashmik Ghaznian, Guan Huei Lee, Duan Zhongping, Ajit Sood, Omesh Goyal, Laurentius A. Lesmana, Rinaldi C. Lesmana, Sombat Treeprasertsuk, Nan Yuemin, Samir Shah, Han Tao, V. M. Dayal, Xin Shaojie, Fazal Karim, Zaigham Abbas, Jose D. Sollano, Kemal Fariz Kalista, Ananta Shreshtha, Diana Payawal, Masao Omata, Shiv Kumar Sarin declare no competing interests.

Competing interests

None of the authors had any competing interests.

Financial disclosure

None.

Grant support

None.

Role of medical writer

None.

Patient consent

Waived off.

Guarantor of the article

Shiv Kumar Sarin and Anoop Saraya.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The members of the APASL ACLF Research Consortium (AARC) for APASL ACLF Working Party are listed in Acknowledgements.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, S., Agarwal, S., Saraya, A. et al. Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC). Hepatol Int 16, 1234–1243 (2022). https://doi.org/10.1007/s12072-022-10372-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-022-10372-1

Keywords

Navigation